Active · per the CBE, 17 November 2026

Merendree Pharma

BE0504865006

Rechtspersoon Private limited company 1 establishment

Merendree Pharma is a pharmacy in Deinze. Private Limited, started on 7 February 2013, 1 establishment.

Veldestraat 65 box E, 9850 Deinze

Behind the company: Céline Mattelin.

Active for

13 year, 9 months

Financials

Financial year 2026

Merendree Pharma from Deinze, company number BE0504865006, closed financial year 2026 with a result of € 60,077 after tax. For that financial year Merendree Pharma recorded a gross margin of € 136,204 and equity of € 264,470. Compared with financial year 2025, the result moved from € 57,939 to € 60,077. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 12, 2026.

What it is worth Healthy

€ 264,470

▼ 6% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 60,077

▲ 4% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 197,692

▲ 23% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 76,780 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2026

Vehicles and equipment

€ 17,803

▼ 31% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 1 years to go

€ 25,839

▼ 59% vs 2025

€ 20,811 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 29,074

▼ 4% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,797

▼ 25% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
2023202420252026Change 2025 → 2026
Gross margin € 119,886 € 126,462 € 135,847 € 136,204
Profit after taxes € 51,710 € 51,022 € 57,939 € 60,077 ▲ 4%
Equity € 254,338 € 276,333 € 281,173 € 264,470 ▼ 6%
Total debts € 266,355 € 189,123 € 159,844 € 186,455 ▲ 17%
Cash € 168,536 € 145,548 € 160,878 € 197,692 ▲ 23%
Retained profit € 248,138 € 270,133 € 274,973 € 258,270 ▼ 6%
Dividend € 26,188 € 29,027 € 53,100 € 76,780 ▲ 45%
Bank debt € 137,191 € 100,649 € 63,536 € 25,839 ▼ 59%
Balance sheet total € 520,693 € 465,456 € 441,017 € 450,925 ▲ 2%

By gross margin, Merendree Pharma ranks 3rd of 7 companies with main activity “Detailhandel in farmaceutische producten” in Deinze that publish figures (fiscal year 2026).

Key figures of Merendree Pharma, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 30 January 2028.

What happened to Merendree Pharma?

What happened at Merendree Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2026: profit of € 60,077 (▲ 4% vs 2025). Source: NBB ↗
  • Céline Mattelin became a director. NBB
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Deinze. KBO

In short

From € 51,710 profit in 2023 to € 60,077 profit in 2026.

Paid € 77,826 in corporate taxes since 2023.

Best year ever: 2026, with € 60,077 profit.

Paid out € 185,094 in dividends to the owners in total.

Management

Céline Mattelin
Merendree Pharma

Behind Merendree Pharma is Céline Mattelin.

Directors

According to the 2026 annual accounts

Céline Mattelin

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Veldestraat 65 box E

9850 Deinze

2.218.061.584

Veldestraat 65 E

9850 Deinze

Active since 7 February 2013

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Deinze

Same main activity (Detailhandel in farmaceutische producten), 6 active companies in Deinze, largest first.

VIDAFAR

€ 331,134 gross margin · 2025

APOTHEEK VOSSELARE

€ 138,106 gross margin · 2025

DEGROFARM

€ 113,527 gross margin · 2026

VERBOFAR

€ 84,698 gross margin · 2025

LEVEUGLE

€ 78,564 gross margin · 2025

UNIPER

€ 6,481 gross margin · 2025

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • MATTELIN, Wim Joris(oprichter) 50%
  • GOOSSENS, Isabelle Marcelle Céleste(oprichter) 50%

Details

Company number
0504.865.006
VAT number
BE 0504.865.006
Registered office
Veldestraat 65 bus E, 9850 Deinze
Names & denominations
Merendree Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
7 February 2013
Peppol
Active · Active since 29 Mar 2024
Activities · NACE

Detailhandel in farmaceutische producten

Frequently asked questions

What does Merendree Pharma do?
Merendree Pharma is a pharmacy in Deinze. Private Limited, started on 7 February 2013, 1 establishment.
What is the address of Merendree Pharma?
The registered office of Merendree Pharma is located at Veldestraat 65 box E, 9850 Deinze.
Is Merendree Pharma still active?
Yes. According to the CBE (17 November 2026) Merendree Pharma is active, legal situation “Normale toestand”, started on 7 February 2013.
Is Merendree Pharma registered on Peppol?
Yes, Merendree Pharma is registered on the Peppol network with ID 0208:0504865006.
What is the enterprise number of Merendree Pharma?
The enterprise number of Merendree Pharma is BE0504865006.
When was Merendree Pharma founded?
Merendree Pharma was founded on 7 February 2013.